CCM
ATRS

Coe Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Coe Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-97,475
Closed -$341K – 261
2014
Q1 		$341K Sell
97,475
-290,000
-75% -$1.29M 0.1% 202
2013
Q4 		$1.73M Buy
+387,475
New +$1.58M 0.61% 43

Other funds holding ATRS

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHI
William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Coe Capital Management's ATRS Position: Q2 2014 in Review

Coe Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2014, closing a stake of 97,475 shares — an estimated $341K sold.

Coe Capital Management first reported a position in ATRS in Q4 2013 and held it in 2 quarters. The position peaked at $1.73M in Q4 2013. 85 funds tracked by Wall St. Rank hold ATRS as of Q2 2014.

  • Coe Capital Management reported no remaining Antares Pharma, Inc. position as of Q2 2014 after selling out during the quarter.
  • Coe Capital Management sold 97,475 Antares Pharma, Inc. shares in Q2 2014, an estimated $341K.
  • Coe Capital Management first reported a position in Antares Pharma, Inc. in Q4 2013 and held it in 2 quarters.
  • Coe Capital Management's Antares Pharma, Inc. position peaked at $1.73M in Q4 2013.
  • 85 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2014.

Based on Coe Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.